Nautilus Biotechnology, Inc. Ratios

Ratios Dec2021 Dec2022 Dec2023 Dec2024
Profitability
FCF Margin 28,431.51%39,450.82%74,182.19%72,936.90%
Valuation
Enterprise Value 643.18M224.50M373.59M210.95M